Fluoroquinolone-Resistant Escherichia coli in the Long-Term Care Setting

American Journal of Medicine

Volumn 119, Issue 11, 2006, Pages 958-963

  Cohen, Alana E ^a   Lautenbach, Ebbing ^b,c,d,e   Morales, Knashawn H ^b,d,e   Linkin, Darren R ^b,c,e,f  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Division of Infectious Diseases   (United States)

^d Department of Biostatistics and Epidemiology Philadelphia ^*  (United States)

^e Center for Clinical Epidemiology and Biostatistics   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antimicrobial drug resistance; Drug resistance; Fluoroquinolones; Long term care; Microbial; Urinary tract infections

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HUMAN; LONG TERM CARE; MALE; MEDICAL RESEARCH; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; URINARY TRACT INFECTION;

AGED; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FLUOROQUINOLONES; HUMANS; LONG-TERM CARE; MALE; NURSING HOMES; PHILADELPHIA; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; URINARY TRACT INFECTIONS;

EID: 33750334103     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.05.030     Document Type: Article

References (26)

1. Tartaglione T.A., Raffalovich A.C., Poynor W.J., Espinel-Ingroff A., and Kerkering T.M. Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral doses. Antimicrob Agents Chemother 29 1 (1986) 62-66
2. Lautenbach E., Larosa L.A., Kasbekar N., Peng H.P., Maniglia R.J., and Fishman N.O. Fluoroquinolone utilization in the emergency departments of academic medical centers: prevalence of, and risk factors for, inappropriate use. Arch Intern Med 163 5 (2003) 601-605
3. Viray M., Linkin D., Maslow J.N., et al. Longitudinal trends in antimicrobial susceptibilities across long-term-care facilities: emergence of fluoroquinolone resistance. Infect Control Hosp Epidemiol 26 1 (2005) 56-62
4. Strausbaugh L.J., Crossley K.B., Nurse B.A., and Thrupp L.D. Antimicrobial resistance in long-term-care facilities. Infect Control Hosp Epidemiol 17 2 (1996) 129-140
5. Jones A. The National Nursing Home Survey: 1999 summary. Vital Health Stat 13 152 (2002) 1-116
6. Nicolle L.E., Strausbaugh L.J., and Garibaldi R.A. Infections and antibiotic resistance in nursing homes. Clin Microbiol Rev 9 1 (1996) 1-17
7. Castle N.G., and Mor V. Hospitalization of nursing home residents: a review of the literature, 1980-1995. Med Care Res Rev 53 2 (1996) 123-148
8. Fried T.R., Gillick M.R., and Lipsitz L.A. Whether to transfer?. Factors associated with hospitalization and outcome of elderly long-term care patients with pneumonia. J Gen Intern Med 10 5 (1995) 246-250
9. Irvine P.W., Van Buren N., and Crossley K. Causes for hospitalization of nursing home residents: the role of infection. J Am Geriatr Soc 32 2 (1984) 103-107
10. Strausbaugh L.J., and Joseph C.L. The burden of infection in long-term care. Infect Control Hosp Epidemiol 21 10 (2000) 674-679
11. Warshaw G., Mehdizadeh S., and Applebaum R.A. Infections in nursing homes: assessing quality of care. J Gerontol A Biol Sci Med Sci 56 2 (2001) M120-M123
12. Muder R.R., Brennen C., Goetz A.M., Wagener M.M., and Rihs J.D. Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center. Antimicrob Agents Chemother 35 2 (1991) 256-258
13. Lucet J.C., Chevret S., Decre D., et al. Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin Infect Dis 22 3 (1996) 430-436
14. Lautenbach E., Fishman N.O., Bilker W.B., et al. Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections. Arch Intern Med 162 21 (2002) 2469-2477
15. Ena J., Amador C., Martinez C., and Ortiz de la Tabla V. Risk factors for acquisition of urinary tract infections caused by ciprofloxacin resistant Escherichia coli. J Urol 153 1 (1995) 117-120
16. Richard P., Delangle M.H., Merrien D., et al. Fluoroquinolone use and fluoroquinolone resistance: is there an association?. Clin Infect Dis 19 1 (1994) 54-59
17. Carratala J., Fernandez-Sevilla A., Tubau F., Callis M., and Gudiol F. Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin. Clin Infect Dis 20 3 (1995) 557-560 discussion 561-553
18. Pena C., Albareda J.M., Pallares R., Pujol M., Tubau F., and Ariza J. Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections. Antimicrob Agents Chemother 39 2 (1995) 520-524
19. Harris A.D., Samore M.H., Lipsitch M., Kaye K.S., Perencevich E., and Carmeli Y. Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli. Clin Infect Dis 34 12 (2002) 1558-1563
20. Hooper D.C., Wolfson J.S., and Swartz M.N. Mechanisms of action and resistance to ciprofloxacin. Am J Med 82 suppl 4A (1987) 12-20
21. Clinical Laboratory Standards Institute. Current Versions of CLSI Documents. Available at: http://www.clsi.org/Source/Currentdocs.cfm?Section=Current_Versions_of_CLSI_Documents&CFID=346231&CFTOKEN=7525313/. Accessed August 28, 2006.
22. McGeer A., Campbell B., Emori T.G., et al. Definitions of infection for surveillance in long-term care facilities. Am J Infect Control 19 1 (1991) 1-7
23. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 5 (1987) 373-383
24. National Nosocomial Infections Surveillance (NNIS) System Report. data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32 8 (2004) 470-485
25. Zervos M.J., Hershberger E., Nicolau D.P., et al. Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. Clin Infect Dis 37 12 (2003) 1643-1648
26. Karlowsky J.A., Thornsberry C., Jones M.E., and Sahm D.F. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin. Clin Infect Dis 36 2 (2003) 183-187